HIV Virtual Education Summit What’s New, Different, and Critical to Know in Management of HIV in (HIV2012)

Venue: Virtual Education Conference

Location: Boston, MA, -

Event Date/Time: May 16, 2012 End Date/Time: Jan 16, 2013
Report as Spam

Description

HIV Virtual Education Summit

What’s New, Different, and Critical to Know in Management of HIV in 2012


WHAT
National experts in HIV management to meet–live & online–for a virtual education congress.
Choose from three 1-hour interactive CME sessions.

WHERE
http://www.idcarelive.com/en_CA/br/HIV/refcode=allconferences
Register now, there’s no cost to participate

WHEN
Wednesday, May 16, 2012, 11:00 AM – 3:00 PM ET

Venue

Online
Boston
MA
-
MORE INFO ON THIS VENUE

Additional Information

Presented by the Johns Hopkins University School of Medicine HIV Virtual Education Summit Choose From Three 1-Hour Interactive CME Sessions. Wednesday, May 16, 2012 11:00 AM Highlights of CROI 20121: Meeting Highlights and Implications Speaker: Paul Sax, MD, Director of the HIV Program and Division of Infectious Diseases at Brigham and Women's Hospital 1:00 PM Novel Treatment Strategies for HIV/AIDS: NRTI Sparing, Monotherapies, and Eradication Speaker: Ian Frank, MD, Director of the Clinical-Therapeutics Program of the Penn Center for AIDS Research 2:00 PM Immune Activation and Inflammation--What to Measure and What to Do About It? Speaker: David Wohl, MD, Co-Director, UNC AIDS Clinical Trials Unit Sign up at www.IDCareLive.com there’s no cost to participate. The Johns Hopkins University School of Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ACKNOWLEDGEMENT Supported by educational grants from Boehringer Ingelheim and Gilead Sciences TUITION Complimentary ACCREDITATION STATEMENT The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CREDIT DESIGNATION STATEMENTS The Johns Hopkins University School of Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. OTHER CREDITS American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 3 hours of credit for completing these programs. DATE OF RELEASE/EXPIRATION Live sessions will be available Wednesday, May 16, 2012 from 11:00 AM- 3:00 PM ET LEARNING OBJECTIVES After participating in this activity, the participant will demonstrate the ability to: • Choose appropriate HAART’s for treatment-native patients with HIV to meet individual needs. • Identify the best course of action for HIV patients failing on standard HAART • Apply changes incorporated in the recent guidelines’ revision to clinical practice • Integrate new research data on prevention of HIV transmission • Describe strategies for improving compliance with HAART, including therapy simplification whenever appropriate • Incorporate newly approved ARTs to minimize resistance and improve tolerability TARGET AUDIENCE Infectious disease specialists, HIV specialists, primary care physicians, internal medicine practitioners, pathologists, epidemiologists, obstetricians/gynecologists, and other healthcare providers caring for patients with HIV will constitute the primary audience for this event. The secondary audience may include nurses, nurse practitioners, physician assistants, and pharmacists. FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES It is the policy of the Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the course handout materials.